StratifAI, the AI precision oncology company behind the Polaris™ platform, today announced its selection for the ...
Is Social Isolation an Overlooked Risk Factor in Cancer Mortality? People with cancer who experience loneliness or social ...
I went into cancer care and cancer research because, when I was a fellow, it was the medical specialty with the largest ...
More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings ...
The five-year invasive disease-free survival (iDFS) rates were 85.5% in the Kisqali plus ET arm versus 81.0% in the ET alone arm, representing a clinically meaningful 4.5% improvement 1. These ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated, commercial biotechnology ...
BV usually recurs (meaning, it comes back). Up to 66% percent of women with bacterial vaginosis will have it again within a ...
PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR 0.72) versus SoC alone, with positive trend in OS (HR 0.84) in PSMA+ metastatic ...
Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo 1 IMvigor011 is the first global phase III study to read out pioneering a ctDNA- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback